Funding Cycle XII – Letters of Intent Submission in April 2004
The Roche Organ Transplantation Research Foundation (ROTRF) is very pleased to announce that ten applications have been awarded grants in the latest cycle of funding. The grants allocated in this cycle total 2.1 million Swiss francs (CHF). The Board of Trustees and the Scientific Advisory Committee (SAC) of the ROTRF were once again very pleased with the high quality and innovation demonstrated in the applications received.
The ROTRF received 96 Letters of Intent in funding cycle XII up to the deadline submission (April 2004) from scientists around the world. Of the applications, 46.9% were received from Europe, the major countries being the UK (10.4%), France (10.4%) and Germany (7.3%), while 45.8% came from the United States (39.6%) and Canada (6.2%). Asia (4.2%), Australia/New Zealand (2.1%) and South America (1%) accounted for the remaining 7.3% of the applications.
Based on the evaluation and reviews of the Scientific Advisory Committee, the Board of Trustees invited the 22 top-ranked applicants to submit a Full Paper Application. After thorough review of the Full Paper Applications, the Board of Trustees awarded ten full or partial grants of up to 300'000 CHF to five applicants from the USA, two from the UK and one each from Finland, Canada and France.
The abstracts of these newly awarded grants are published in the first pages of this Biannual Report and on the ROTRF homepage. The funded projects focus on the induction of tolerance, mechanisms of long-term graft survival, organ rejection, and identification of donor organ characteristics required for the optimal organ function and survival after transplantation.